Azalanstat
Azalanstat (RS 21607) is an orally available selective mammalian lanosterol 14-alpha-demethylase inhibitor with hypocholesterolemic activity that inhibits cholesterol synthesis in HepG2 cells, human fibroblasts, hamster hepatocytes, and hamster livers through inhibition of the cytochrome P450 enzyme, lanosterol 14 alpha demethylase.
Product Specifications
CAS Number
143393-27-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
429.96
Molecular Formula
C22H24ClN3O2S
Notes
Research use only, not for human use.
Receptor
P450
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS606465-01 0.1 mg
Ephrin type-B Receptor 2 (Tyrosine-protein kinase receptor EPH-3, DRT, Receptor protein-kinase HEK5, ERK, Tyrosine-protein kinase TYRO5, Renal carcinoma antigen NY-REN-47, EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO4)
Ask
View Details MBS606465-02 5x 0.1 mg
Ephrin type-B Receptor 2 (Tyrosine-protein kinase receptor EPH-3, DRT, Receptor protein-kinase HEK5, ERK, Tyrosine-protein kinase TYRO5, Renal carcinoma antigen NY-REN-47, EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO4)
Ask
View Details